Loading verified market, valuation, and statement data.
2. Company Fundamentals
2.1 Competitiveness
| Metric |
Value |
| Operating Margins |
41.62% |
| Profit Margins |
41.58% |
| Return on Equity |
34.4% |
| Return on Assets |
11.99% |
| Free Float |
0.11B |
| Short Int % Utilisation |
6.67% |
2.2 Growth
| Metric |
Value |
| Revenue Growth |
21.7% |
| Free Cash Flow |
0.99B |
| EBITDA |
12.54 (Ratio) |
| Enterprise Value |
16.54B |
| EV/Revenue |
5.52 |
| EV/EBITDA |
12.54 |
Revenue growth of 21.7% places the company in a high-growth category.
2.3 Management
| Role |
Metric |
| Consensus Rating |
N/A |
2.4 Return
| Metric |
Value |
| Expected Return (Ann.) |
4.32% |
| Risk / Std Dev (Ann.) |
30.24% |
| Sharpe Ratio (rf=4.5%) |
-0.01 |
| Beta |
0.97 |
2.5 FCFF DCF Valuation
Valuation basis: This research model follows a five-year, unlevered FCFF DCF. It starts from reported annual operating inputs, forecasts revenue and operating cash conversion under an explicit mechanical policy, discounts FCFF at WACC, applies a Gordon-growth terminal value, and bridges enterprise value to an indicative common-equity value per share. It is an analytical estimate rather than a recommendation or personalised target price.
Step 1 — Forecast Operating Profit and NOPAT
| Reported operating input |
Value |
| Revenue |
$2.74B |
| Prior annual revenue |
$2.30B |
| EBIT |
$997.20M |
| Tax rate |
20.00% |
| NOPAT = EBIT × (1 − tax rate) |
$797.76M |
| Forecast start-growth basis |
15.00% |
| Forecast policy |
latest reported annual revenue growth, bounded to -10.00% / 15.00% |
Step 2 — Calculate FCFF
| Current FCFF building block |
Value |
| NOPAT |
$797.76M |
| Add: depreciation & amortisation |
$135.42M |
| Less: capital expenditure |
-$11.01M |
| Less/(add): working-capital cash-flow movement |
-$188.12M |
| Current unlevered FCFF |
$734.04M |
Explicit FCFF forecast
| Forecast year |
Revenue growth |
NOPAT |
D&A |
Capex |
Change in NWC |
FCFF |
Present value |
| 1 |
15.00% |
$917.42M |
$155.73M |
-$12.66M |
-$216.34M |
$844.15M |
$806.17M |
| 2 |
11.88% |
$1.03B |
$174.22M |
-$54.18M |
-$242.03M |
$904.38M |
$787.72M |
| 3 |
8.75% |
$1.12B |
$189.47M |
-$102.43M |
-$263.21M |
$939.99M |
$746.72M |
| 4 |
5.62% |
$1.18B |
$200.12M |
-$154.16M |
-$278.02M |
$946.90M |
$686.05M |
| 5 |
2.50% |
$1.21B |
$205.13M |
-$205.13M |
-$284.97M |
$923.46M |
$610.21M |
Step 3 — Determine the Discount Rate (WACC)
| WACC input |
Value |
| Risk-free rate |
4.71% |
| Equity risk premium assumption |
5.50% |
| Beta |
0.99 |
| Cost of equity |
10.15% |
| Pre-tax cost of debt |
4.67% |
| WACC |
9.64% |
| WACC validation |
within standard range |
Step 4 — Estimate Terminal Value
| Terminal-value input |
Value |
| Perpetuity growth rate |
2.50% |
| Terminal value |
$13.25B |
| Implied terminal EV / EBITDA |
7.72x |
| Terminal value as % of enterprise value |
69.69% |
Step 5 — Discount Cash Flows to Enterprise Value
| Enterprise-value component |
Value |
| Present value of explicit FCFF |
$3.64B |
| Present value of terminal value |
$8.36B |
| Indicated enterprise value |
$12.00B |
| Discounting convention |
mid-year for explicit FCFF; terminal value discounted at year-end five |
Step 6 — Convert Enterprise Value to Equity Value
| Equity bridge |
Value |
| Indicated enterprise value |
$12.00B |
| Less: gross interest-bearing debt |
$1.37B |
| Add: cash and equivalents |
$184.41M |
| Add: affiliate investments |
$0.00 |
| Less: minority interests |
$0.00 |
| Indicated common equity value |
$10.81B |
Step 7 — Calculate Indicative Value Per Share
| Per-share output |
Value |
| Shares used |
120,777,000.00 |
| Share-count basis |
reported diluted weighted-average shares |
| Current market price |
$148.76 |
| DCF indicative value per share |
$89.52 |
| Indicative value vs. market price |
-39.82% |
Model Integrity Checks
| Check |
Result |
| Perpetuity growth is below the risk-free rate |
pass |
| Perpetuity growth is below WACC |
pass |
| WACC is within the configured operating-company range |
pass |
| Terminal-year FCFF is positive |
pass |
| Terminal capex converges to D&A |
pass |
| Terminal-value concentration |
within review band |
| Implied price differs from spot by more than 30% |
review required |
2.6 Investor-Style Research Screen
| Educational screen |
Result |
| Buffett-inspired cash-quality checks |
4/4 evidenced checks |
| Lynch-inspired balance-and-growth checks |
4/4 evidenced checks |